EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention

Ezgi Eroglu iD, Nusin Harmanci iD

Basic & Clinical Pharmacology & Toxicology · 2025-10 · 137 (4)

DOI: 10.1111/bcpt.70107 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 08.09.2025. Verfasst von Ezgi Eroglu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Trials, Turkish Medicines and Medical Devices Agency, Ankara, Turkey. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Molecular Targeted Therapy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis and frontotemporal dementia represent a significant global health burden with limited therapeutic options. Current treatments are primarily symptomatic and fail to modify disease progression, emphasizing the urgent need for novel, mechanism‐based interventions. Recent advances in molecular neuroscience have identified several non‐classical pathogenic pathways, including neuroinflammation, mitochondrial dysfunction, impaired autophagy and proteostasis, synaptic degeneration and non‐coding RNA dysregulation. In this focused review, we highlight emerging molecular targets such as TREM2, NLRP3, mTOR, TFEB, PINK1 and SIRT3, which offer promising avenues for therapeutic intervention. We also address challenges in target validation and translational drug development, while proposing future research directions that may facilitate the design of more effective treatments. A deeper understanding of these molecular mechanisms is essential for developing disease‐modifying strategies to combat neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesMolecular Targeted TherapyHumansAnimalsAutophagyDrug Development

Stichwörter der Autor:innen

Alzheimer's diseaseautophagymolecular targetsneurodegenerationneuroinflammation

Autor:innen und Institutionen

  • Department of Clinical Trials, Turkish Medicines and Medical Devices Agency, Ankara, Turkey.
  • Department of Medical Pharmacology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.

ORCID-Profile: Ezgi Eroglu, Nusin Harmanci

Zitieren

APA

Eroglu, E., & Harmanci, N. (2025). Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention. Basic & Clinical Pharmacology & Toxicology, 137(4). https://doi.org/10.1111/bcpt.70107

Vancouver

Eroglu E, Harmanci N. Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention. Basic & Clinical Pharmacology & Toxicology. 2025;137(4). doi:10.1111/bcpt.70107

BibTeX
@article{Eroglu2025,
  author = {Eroglu, Ezgi and Harmanci, Nusin},
  title = {Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2025},
  volume = {137},
  number = {4},
  doi = {10.1111/bcpt.70107}
}
Kostenlos starten →